Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age (years) | ||||
 < 68 | Ref. |  | Ref. |  |
 ≥ 68 | 1.44 (1.06–1.94) | 0.02 | 1.51 (1.09–2.10) | 0.01 |
Adjuvant chemotherapy | Â | Â | NE | Â |
 No | Ref. |  |  |  |
 Yes | 1.01 (0.75–1.37) | 0.95 |  |  |
Sex | Â | Â | NE | Â |
 Male | Ref. |  |  |  |
 Female | 0.77 (0.57–1.04) | 0.09 |  |  |
BRAF status | Â | Â | NE | Â |
 Wildtype | Ref. |  |  |  |
 Mutant | 1.05 (0.60–1.81) | 0.90 |  |  |
KRAS status | ||||
 Wildtype | Ref. |  | Ref. |  |
 Mutant | 1.39 (1.03–1.88) | 0.03 | 1.38 (1.00–1.89) | 0.05 |
TP53 status | Â | Â | NE | Â |
 Wildtype | Ref. |  |  |  |
 Mutant | 1.18 (0.82–1.68) | 0.37 |  |  |
CIMP status | Â | Â | NE | Â |
 Negative | Ref. |  |  |  |
 Positive | 0.97 (0.63–1.49) | 0.90 |  |  |
CIN status | Â | Â | NE | Â |
 Negative | Ref. |  |  |  |
 Positive | 0.80 (0.54–1.19) | 0.26 |  |  |
MMR status | Â | Â | Â | Â |
 pMMR | Ref. |  | NE |  |
 dMMR | 0.79 (0.48–1.30) | 0.35 |  |  |
Tumor location | Â | Â | NE | Â |
 Proximal colon | Ref. |  |  |  |
 Distal colon | 0.91 (0.67–1.23) | 0.55 |  |  |
CIT subtype | ||||
 C4C6 | Ref. |  | Ref. |  |
 Others | 0.61 (0.44–0.84) | 0.002 | 0.92 (0.64–1.34) | 0.68 |
TNM stage | ||||
 I + II | Ref. |  | Ref. |  |
 III + IV | 1.98 (1.45–2.70) | < 0.001 | 1.52 (1.10–2.11) | 0.01 |
 MRS | 15.89 (9.97–25.33) | < 0.001 | 13.59 (8.12–22.72) | < 0.001 |